openPR Logo
Press release

Less than 2 weeks to go until the 13th annual ADMET event in London

06-27-2018 12:05 PM CET | Health & Medicine

Press release from: SMi Group

Less than 2 weeks to go until the 13th annual ADMET event in London

SMi’s 13th annual ADMET conference is set to commence on the 9th and 10th July. This year's two-day event will bring together a global audience of DMPK scientists, toxicologists and senior industry thought-leaders dedicated to addressing the current market challenges, driven by an increased demand for screening and advances in technology.

Delegates will have the opportunity to network and hear insightful presentations and case studies on topics such as toxicology research strategies, modelling techniques, predictive pharmacology, pre-clinical DMPK studies, and many more.

Spotlight Presentations and Speakers:

“KPB – Strengths and limitations of compartmental modelling”, presented by Sheila-Annie Peters, Head, Translational Quantitative Pharmacology, Merck Serono. Peters will discuss the topics of the making of a successful drug candidate, as well as defining parameters in acute and chronic toxicity evaluations, drug safety testing, and cost-benefit assessments.

“Intracellular pharmacokinetics: Emerging opportunities for tailoring project support”, presented by Andreas Reichel, Vice President, Research Pharmacokinetics, Bayer. Reichel’s presentation will focus on the mechanisms that control intracellular drug concentrations, experimental approaches that are suitable to estimate unbound intracellular concentrations in selected cell types as well as their applicability to advance our understanding of intracellular drug-target interactions. In addition, sase studies will be shown to illustrate how the field of ICPK can offer novel opportunities that can be used to address key questions in drug discovery projects, thereby enhancing our understanding of the intracellular fate of drugs.

2018 Event Agenda:

Day 1: Opening keynote from AbbVie by Vice President, Global Pre-Clinical Safety, Senior Research Fellow, Eric Blomme on Novel technologies and computational tools in discovery toxicology: opportunities and challenges - his exclusive speaker Q&A interview is available on the event website’s download centre.

Day 2: Opening keynote from Vertex Pharmaceuticals by Peter Littlewood, Director of DMPK. The talk will discuss Human PK and dose predictions for compounds with challenging physiochemical profiles.

With the conference fast-approaching, places are now limited and potential attendees are urged to book soon at an exclusive price of £999 available for a limited time, to avoid disappointment. For the full agenda and list of expert speakers, download the latest brochure from the event website, as well as more exclusive free content including speaker interviews, at: www.admet-event.com/openpr

Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk

ADMET
9th – 10th July 2018
Holiday Inn Kensington Forum, London, UK
www.admet-event.com/openpr

Follow us @SMiPharm
#SMiADMET

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

SMi Group Ltd
1 Westminster Bridge Rd, South Bank, London SE1 7XW
Simi Sapal
ssapal@smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Less than 2 weeks to go until the 13th annual ADMET event in London here

News-ID: 1099881 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for ADMET

Pharma ADMET Testing Market 2022 - How Business will Grow in 2028?
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study. The pharma ADMET testing market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028. The report highlights trends prevailing in the market and factors
Dr. Eric Blomme, AbbVie, Chair Invite & Interview Snippet for ADMET
The 13th annual ADMET conference, commencing 9 – 10 July 2018 in London, UK, will be chaired by Dr Eric Blomme, Vice President of Development Biological Sciences at AbbVie. Ahead of this year’s conference, Dr Blomme invites ADMET professionals and discusses the event in his exclusive interview with SMi, both of which are now available to download on the event website. Dr Eric Blomme has held several positions at Abbott/AbbVie, including
Speaker Interview with Pau Aceves Released - SMi’s 13th Annual ADMET conferenc …
Speaker Interview with Pau Aceves Released - SMi’s 13th Annual ADMET conference The 13th annual ADMET conference is returning to London, UK for an in-depth exploration of the optimisation of ADMET modelling techniques, preclinical DMPK applications and the development of biopharmaceuticals. The event will be taking place at the Holiday Inn Kensington Forum on the 9th and 10th July 2018. An interview with Pau Aceves, Associate Director, Certara Strategic Consulting,
Global Universal Tester Market Forecast 2018-2025 Torontech Group, ADMET, TENSON …
According to a new Market research report by Globeinfo Research, there is an intense competition among the major leading players operating in the global Universal Tester market, including MTS, INSTRON, Zwick/Roell, Shimadzu, ADMET, Hegewald & Peschke, AMETEK(Lloyd), Torontech Group, Keysight Technologies, Qualitest International, Tinius Olsen, Applied Test Systems, ETS Intarlaken, JINAN SHIJIN GROUP, Suns, TENSON, Changchun Kexin Test Instrument and WANCE Group. It analyses the important factors of the Universal
SMi’s 13th Annual ADMET conference 2018 brochure released
The annual ADMET conference is returning to London, UK for its 13th year running and will be taking place at the Holiday Inn Kensington Forum on the 9th and 10th July 2018. The two-day conference will be focused on exploring the optimisation of ADMET modelling techniques, preclinical DMPK applications and the development of biopharmaceuticals. Event highlights include the discussion of cutting-edge toxicology research strategies and how they enable the early prediction of
Biomaterial Testing Equipment Market 2017 - ADMET, MTS Systems, Shimadzu, AMETEK
Apex Research, recently published a detailed market research study focused on the "Biomaterial Testing Equipment Market" across the global, regional and country level. The report provides 360° analysis of "Biomaterial Testing Equipment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Biomaterial Testing Equipment industry, and estimates the future trend of Biomaterial